Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 2/20 | 0.69 |
| ▸ | USP2 | O75604 | 6/20 | 0.44 |
| ▸ | MEN1 | O00255 | 6/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.44 |
| ▸ | BLM | P54132 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | THRB | P10828 | 4/20 | 0.44 |
| ▸ | RECQL | P46063 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | CASP7 | P55210 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 6/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.39 |
| ▸ | GAA | P10253 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15246321 | 0.90 | FTO (0.68) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL31435692 | 0.85 | FTO (0.78) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL3109289 | 0.85 | FTO (0.78) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL16407441 | 0.84 | FTO (0.61) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL17972575 | 0.84 | FTO (0.77) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL24274861 | 0.83 | FTO (0.76) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL10260320 | 0.83 | FTO (0.76) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL15246474 | 0.82 | FTO (0.58) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL21129885 | 0.82 | FTO (0.74) | FTOUSP2MEN1KMT2ABLM | |
| SCHEMBL18972336 | 0.82 | FTO (0.74) | FTOUSP2MEN1KMT2ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11852637-B2 | Bicarbonate biosensors, calcium biosensors, and uses thereof | DUKE UNIVERSITY (US) | 2023-12-26 | — | — | US | claimed |
| US-11402384-B2 | Thermostable glucose biosensors and uses thereof | DUKE UNIVERSITY (US) | 2022-08-02 | — | — | US | disclosed |
| US-11156615-B2 | Glucose biosensors and uses thereof | DUKE UNIVERSITY (US) | 2021-10-26 | — | — | US | disclosed |
| US-20200319194-A1 | UREA BIOSENSORS AND USES THEREOF | DUKE UNIVERSITY | 2020-10-08 | — | — | US | disclosed |
| US-20200271659-A1 | THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF | DUKE UNIVERSITY | 2020-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200271659-A1 | THERMOSTABLE GLUCOSE BIOSENSORS AND USES THEREOF | GCKR, G6PD, GCK | FTO 260/4885USP2 2240/4885MEN1 3358/4885 |
| US-11402384-B2 | Thermostable glucose biosensors and uses thereof | GCKR, G6PD, GCK | FTO 260/4885USP2 2240/4885MEN1 3358/4885 |
| US-11156615-B2 | Glucose biosensors and uses thereof | GCK, GCKR, SLC2A4 | FTO 94/4885USP2 2470/4885MEN1 2391/4885 |
| US-11852637-B2 | Bicarbonate biosensors, calcium biosensors, and uses thereof | CA2, CASR, CACYBP | FTO 1195/4885USP2 2245/4885MEN1 1448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.